Use of a left ventricular assist device (Heart Mate III) as a destination therapy in a patient with chronic heart failure due to Chagas disease. Could it have been avoided?
2023

Heart Mate III Device for Chagas Disease Heart Failure

Sample size: 1 publication 10 minutes Evidence: low

Author Information

Author(s): Tania M. Blanchar-Martínez, Fernando Pío De la Hoz-Restrepo, Seila R. López-Suárez

Primary Institution: Universidad Nacional de Colombia

Hypothesis

Could timely treatment have prevented the need for a left ventricular assist device in a patient with Chagas disease?

Conclusion

Timely intervention in Chagas disease can significantly improve patient outcomes and reduce healthcare costs.

Supporting Evidence

  • The patient experienced significant health deterioration before receiving timely treatment.
  • The Heart Mate III device improved the patient's quality of life after implantation.
  • Chagas disease can lead to severe heart failure if not treated promptly.
  • Public health programs need to focus on timely interventions for Chagas disease.

Takeaway

This study shows that a special heart pump helped a man with a serious heart problem caused by Chagas disease feel much better.

Methodology

The study involved a case report of a patient diagnosed with chronic heart failure due to Chagas disease, who underwent implantation of the Heart Mate III device.

Potential Biases

Potential biases may arise from the subjective nature of patient-reported outcomes.

Limitations

The study is based on a single case report, limiting generalizability.

Participant Demographics

The patient was a 54-year-old male of mixed race, previously employed as a bus driver.

Digital Object Identifier (DOI)

10.15446/rsap.V25n5.106562

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication